EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Tonix Pharmaceuticals Holding Corp. (TNXP) EBITDA Margin data is not available.
| Income Statement Financials | |
$6.88M |
|
$-40.19M |
|
$1.58M |
|
$5.30M |
|
$48.41M |
|
$-41.54M |
|
$1.34M |
|
$-40.19M |
|
$-40.19M |
|
$-40.19M |
|
$-40.19M |
|
$-40.19M |
|
$-40.19M |
|
$-41.54M |
|
$-40.98M |
|
13.71M |
|
13.71M |
|
$-2.93 |
|
$-2.93 |
|
| Balance Sheet Financials | |
$207.17M |
|
$44.89M |
|
$50.74M |
|
$257.91M |
|
$29.65M |
|
-- |
|
$1.13M |
|
$30.77M |
|
$227.14M |
|
$227.02M |
|
$227.14M |
|
14.21M |
|
| Cash Flow Statement Financials | |
$-42.32M |
|
$-1.69M |
|
$20.20M |
|
$209.81M |
|
$186.01M |
|
$-23.80M |
|
$1.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
77.06% |
|
-603.91% |
|
-603.91% |
|
|
EBITDA Margin |
-- |
-584.39% |
|
-584.38% |
|
$-44.01M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.43 |
|
0.78 |
|
115.41 |
|
-17.70% |
|
-17.71% |
|
-15.58% |
|
-17.70% |
|
$15.99 |
|
$-3.21 |
|
$-3.09 |
|